Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Open-market sale Director sold 10,000 shares at $6.11 ($61,100)
  2. 144 Insider Sale of Securities
  3. 4 Open-market sale Director sold 1,830 shares at $4.61 ($8,436)
  4. 8-K Event Executive or director change · Shareholder vote results · Regulation FD disclosure
  5. 4 Grant or award Director acquired 17,430 shares (grant or award)
  6. 4 Grant or award Director acquired 17,430 shares (grant or award)
  7. 4 Grant or award Director acquired 17,430 shares (grant or award)
  8. 4 Grant or award Director acquired 17,430 shares (grant or award)
  9. 4 Grant or award Director acquired 17,430 shares (grant or award)
  10. 4 Grant or award Director acquired 17,430 shares (grant or award)
  11. 4 Grant or award Chairman acquired 17,430 shares (grant or award)
  12. 4 Grant or award Director acquired 17,430 shares (grant or award)
  13. 4 Grant or award Director acquired 17,430 shares (grant or award)
  14. 4 Open-market sale Director sold 1,089 shares at $5.78 ($6,294)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Material agreement · Results of operations · Regulation FD disclosure
  17. 8-K Event Exit or restructuring costs · Regulation FD disclosure
  18. 8-K Event Material agreement · New debt or obligation
  19. 8-K Event Executive or director change
  20. ARS Other Annual Report to Security Holders

Page 12 of 87 · 1,733 filings